Live from the NIH registry
Studies recruiting near Mobile right now
Top 25 of 175 recruiting studies, sorted by proximity — each links to its official registry page
Real-world Experience of Catheter Ablation for the Treatment of Arrhythmias
Paroxysmal Atrial Fibrillation, Persistent Atrial Fibrillation
N/A
Observational 20,000 participants sought
Cardiology Associates of Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Heart Rhythm Clinical and Research Solutions, LLC
Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty
Pain
N/A
Interventional 120 participants sought
Alabama Orthopedic Sports Medicine & Baldwin County Surgery Center — Daphne, Alabama (13.7 mi)
· Sponsor: Synaptrix, Inc.
A Study of Depemokimab in Participants of 6 to 11 Years of Age
Asthma
Phase 3
Interventional 34 participants sought
GSK Investigational Site — Mobile, Alabama (4.5 mi)
· Sponsor: GlaxoSmithKline
Caris Biorepository Research Protocol
Cancer, Early Detection of Cancer
N/A
Observational 100,000 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: Caris Science, Inc.
BMS-986489 (Atigotatug + Nivolumab) vs Durvalumab in Limited-stage Small-cell Lung Cancer (TIGOS-LS)
Limited Stage Small Cell Lung Cancer
Phase 2
Interventional 250 participants sought
Southern Cancer Center — Daphne, Alabama (13.7 mi)
· Sponsor: SCRI Development Innovations, LLC
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
Acute Migraine
Phase 3
Interventional 1,000 participants sought
AMR Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: TriGemX Bio, Inc.
A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2)
Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 600 participants sought
Site 160 — Mobile, Alabama (4.5 mi)
· Sponsor: Merus B.V.
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Diabetic Peripheral Neuropathic Pain
Phase 3
Interventional 1,100 participants sought
AMR Daphne, AL — Daphne, Alabama (13.7 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
Human Papilloma Virus (HPV), High-risk Human Papillomavirus Infection
Phase 2
Interventional 118 participants sought
Velocity Clinical Research - Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Daré Bioscience, Inc.
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
Phase 3
Interventional 1,875 participants sought
USA Health Strada Patient Care Center — Mobile, Alabama (4.5 mi)
· Sponsor: National Cancer Institute (NCI)
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Phase 3
Interventional 1,200 participants sought
USA Mitchell Cancer Institute ( Site 0014) — Mobile, Alabama (4.5 mi)
· Sponsor: Merck Sharp & Dohme LLC
Safety and Efficacy of Boric Acid Inserts for Treatment of Vulvovaginal Candidiasis
Vulvovaginal Candidiases, Vulvovaginal Candidiasis, Genital
Phase 3
Interventional 400 participants sought
Alliance for Multispecialty Research - Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: pH-D Feminine Health LLC
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
Tricuspid Valve Disease
N/A
Interventional 78 participants sought
Springhill Memorial Hospital — Mobile, Alabama (4.5 mi)
· Sponsor: Corvivo Cardiovascular, Inc.
Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)
Platinum-resistant Ovarian Cancer, Platinum-refractory Ovarian Cancer
Phase 3
Interventional 186 participants sought
The University of South Alabama, Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: Genelux Corporation
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Phase 3
Interventional 10,000 participants sought
Mobile Heart USA Health Cardiology Clinic — Mobile, Alabama (4.5 mi)
· Sponsor: Novo Nordisk A/S
Low Voltage Electrical Stimulation for Depression in Parkinson's Patients
Parkinson Disease, Depressive Symptoms
N/A
Interventional 40 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: University of South Alabama
Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula
Pancreatic Carcinoma, Pancreatic Neoplasm
Phase 3
Interventional 274 participants sought
Mobile Infirmary Medical Center — Mobile, Alabama (4.5 mi)
· Sponsor: SWOG Cancer Research Network
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
Ovarian Cancer
Phase 2
Interventional 160 participants sought
Usa Health Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: Incyte Corporation
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Mobile Heart USA Health Cardiology Clinic — Mobile, Alabama (4.5 mi)
· Sponsor: Novo Nordisk A/S
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Cutaneous Melanoma, Stage II
N/A
Interventional 2,998 participants sought
University of South Alabama Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: Melanoma and Skin Cancer Trials Limited
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Hernia, Ventral, Hernia, Inguinal
N/A
Interventional 160 participants sought
University of South Alabama — Mobile, Alabama (4.5 mi)
· Sponsor: Tela Bio Inc
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Phase 2
Interventional 310 participants sought
Site 0170-USA Mitchell Cancer Institute — Mobile, Alabama (4.5 mi)
· Sponsor: K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Heart Failure
Phase 3
Interventional 6,712 participants sought
Diagnostic and Medical Clinic — Mobile, Alabama (4.5 mi)
· Sponsor: Boehringer Ingelheim
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
Uterine Fibroids, Endometriosis
Phase 3
Interventional 1,000 participants sought
Mobile — Mobile, Alabama (4.5 mi)
· Sponsor: Sumitomo Pharma Switzerland GmbH